by Pharm Psych Original | Dec 8, 2013 | NEWS, UPDATES
Granix new growth factor now approved for reduction of neutropenia in patients with non-myeloid malignancies…Learn more Valchlor new topical agent now approved for reduction of stage IA and IB mycosis fungoides…Learn more Opsumit is a new endothelial...
